MNKD vs REGN: Which Stock is Better?

Side-by-side comparison of MannKind Corp and Regeneron Pharmaceuticals Inc in 2026

Comparison Updated:

MNKD

MannKind Corp

REGN

Regeneron Pharmaceuticals Inc

$664.52

Key Metrics Comparison

MetricMNKDREGNWinner
Market Cap$1.28B$59.10BREGN
P/E RatioN/A13.91REGN
EPS (TTM)$N/A$N/ATie
Revenue Growth0.0%0.0%Tie
Gross Margin0.0%0.0%Tie

Analyze MNKD

Full quant analysis

Analyze REGN

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is MNKD or REGN a better investment?

Comparing MNKD and REGN: MannKind Corp has a market cap of $1.28B while Regeneron Pharmaceuticals Inc has $59.10B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between MNKD and REGN?

MNKD (MannKind Corp) and REGN (Regeneron Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: MNKD or REGN?

Based on P/E ratios, compare detailed valuation metrics on our dashboard.

Which is growing faster: MNKD or REGN?

Both MNKD and REGN show similar growth rates. Check our detailed analysis for quarterly trends.

Which company is more profitable: MNKD or REGN?

Both companies show comparable profitability metrics. View the full comparison above for detailed analysis.

Which is the larger company: MNKD or REGN?

Regeneron Pharmaceuticals Inc (REGN) is larger with a market cap of $59.10B compared to $1.28B for MNKD.

Should I buy MNKD or REGN in 2026?

Both MNKD and REGN have investment merit. MNKD trades at $N/A while REGN trades at $664.52. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between MNKD and REGN stock?

Key differences: Market Cap ($1.28B vs $59.10B), P/E Ratio (N/A vs 13.9x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 0.0%).

Should I buy MNKD or REGN in 2026?

The choice between MNKD and REGN depends on your investment goals. REGN shows higher revenue growth (0.0%). REGN has better margins (0.0%). Consider your risk tolerance and time horizon.

What is the market cap comparison between MNKD and REGN?

MNKD (MannKind Corp) has a market cap of $1.28B, while REGN (Regeneron Pharmaceuticals Inc) has a market cap of $59.10B. REGN is the larger company by market value.

Popular Stock Comparisons